Takahashi Miwa, Inoue Kaoru, Yoshida Midori, Morikawa Tomomi, Shibutani Makoto, Nishikawa Akiyoshi
Division of Pathology, National Institute of Health Sciences, 1-18-1 Kamiyoga, Setagaya-ku, Tokyo 158-8501, Japan.
Food Chem Toxicol. 2009 Feb;47(2):462-71. doi: 10.1016/j.fct.2008.12.002. Epub 2008 Dec 10.
Chronic toxicity and carcinogenicity of N-acetylglucosamine (GlcNAc) were examined in male and female F344 rats. GlcNAc was given in the diet at levels of 0%, 1.25%, 2.5% or 5% to groups of 10 rats of each sex for 52 weeks in the chronic toxicity study and 0%, 2.5% or 5% to groups of 50 rats of each sex for 104 weeks in the carcinogenicity study. GlcNAc exerted no toxic effects with regard to clinical signs, mortality, hematology, serum biochemistry and histopathological assessment. Slight suppression of body weight gain was observed at more than 2.5%, but this appeared to be due to slight reduction of caloric intake with the high concentration of test compound, rather than any toxicity. Thus, it was concluded that GlcNAc has neither toxic nor carcinogenic effects in F344 rats, the no observed adverse effect levels (NOAEL) estimated from the chronic toxicity study being 5% in both sexes, equivalent to 2323 and 2545 mg/kg/day in males and females, respectively.
在雄性和雌性F344大鼠中检测了N-乙酰葡糖胺(GlcNAc)的慢性毒性和致癌性。在慢性毒性研究中,将GlcNAc以0%、1.25%、2.5%或5%的水平添加到每组10只各性别的大鼠饮食中,持续52周;在致癌性研究中,将其以0%、2.5%或5%的水平添加到每组50只各性别的大鼠饮食中,持续104周。在临床症状、死亡率、血液学、血清生物化学和组织病理学评估方面,GlcNAc未产生毒性作用。在超过2.5%的剂量下观察到体重增加略有抑制,但这似乎是由于高浓度受试化合物导致热量摄入略有减少,而非任何毒性作用。因此,得出结论,GlcNAc对F344大鼠既无毒性也无致癌性,根据慢性毒性研究估计的未观察到有害作用水平(NOAEL)在两性中均为5%,分别相当于雄性和雌性大鼠每日2323和2545 mg/kg。